US 11191844
Multispecific antigen-binding molecules and uses thereof
granted A61KA61K2039/507A61K2039/572
Quick answer
US patent 11191844 (Multispecific antigen-binding molecules and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2039/507, A61K2039/572, A61K47/68033, A61K47/6849